BofA/Merrill Lynch upgraded Edwards Lifesciences (NYSE: EW) from Neutral to Buy with a price target of $130.00.

For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.

Shares of Edwards Lifesciences closed at $108.35 yesterday.

Upgrades

Edwards Lifesciences (EW) PT Raised to $140 at Canaccord GenuityJuly 27, 2016 10:15 AM Edwards Lifesciences (EW) PT Raised to $139 at UBS Amid Strong Q2July 27, 2016 8:14 AM Edwards Lifesciences (EW): THV Is The Key, Raising PT - LeerinkJuly 27, 2016 7:15 AM Edwards Lifesciences (EW) Tops Q2 EPS by 6c; Guides AboveJuly 26, 2016 4:17 PM Edwards Lifesciences Reports Second Quarter ResultsJuly 26, 2016 4:15 PM